Anatruxonium
| Anatruxonium | |
|---|---|
| [[File:|frameless|220px|alt=|Chemical structure of Anatruxonium]] | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Anatruxonium is a synthetic compound that has been studied for its potential use in medical applications, particularly as a neuromuscular blocking agent. It belongs to the class of quaternary ammonium compounds, which are known for their ability to interfere with neurotransmission at the neuromuscular junction.
Pharmacology
Anatruxonium acts as a competitive antagonist at nicotinic acetylcholine receptors located at the neuromuscular junction. By binding to these receptors, it prevents acetylcholine from attaching and activating them, leading to muscle relaxation and paralysis. This mechanism is similar to that of other neuromuscular blockers such as succinylcholine and rocuronium.
Clinical Applications
While Anatruxonium has been primarily studied in experimental settings, its potential clinical applications include use as a muscle relaxant during surgical procedures. Its effects are reversible, which makes it suitable for use in controlled medical environments where rapid recovery of muscle function is desired.
Side Effects
As with other neuromuscular blocking agents, the use of Anatruxonium can lead to side effects such as prolonged muscle paralysis, respiratory depression, and cardiovascular effects. Careful monitoring and dosage adjustments are necessary to minimize these risks.
Research and Development
Research on Anatruxonium is ongoing, with studies focusing on its pharmacokinetics, safety profile, and potential advantages over existing neuromuscular blockers. Its unique chemical structure may offer benefits in terms of onset and duration of action.
Also see
- Neuromuscular junction
- Acetylcholine
- Quaternary ammonium compound
- Muscle relaxant
- Succinylcholine
- Rocuronium
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
